| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2007 | US20070167469 Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof |
| 07/19/2007 | US20070167468 Substituted bicyclic 8-pyrr0lidinoxanthines, methods for their production, pharmaceutical formulations and their use |
| 07/19/2007 | US20070167467 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 07/19/2007 | US20070167466 "Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use" |
| 07/19/2007 | US20070167461 USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a] PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS |
| 07/19/2007 | US20070167460 Acetylenyl-pyrazolo-pyrimidine derivatives |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167458 Tetrahydro-naphthalene and urea derivatives |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167456 Mercaptoimidazoles as ccr2 receptor antagonists |
| 07/19/2007 | US20070167455 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 07/19/2007 | US20070167454 Methods for treating hypertension |
| 07/19/2007 | US20070167453 6-[4-(3-piperidin-1-ylpropoxy)-phenyl]-[1,2,4]triazolo[4,3-b]pyridazine; has histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect; for metabolic system, circulatory system or nervous system diseases |
| 07/19/2007 | US20070167452 Therapeutic amide derivatives |
| 07/19/2007 | US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES |
| 07/19/2007 | US20070167450 Agent for treating chronic pelvic pain syndrome |
| 07/19/2007 | US20070167449 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 07/19/2007 | US20070167448 Derivatives of sulphonamides, their preparation and use as medicaments |
| 07/19/2007 | US20070167447 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 07/19/2007 | US20070167446 Neuroprotective compounds and pharmaceutical compositions comprising them |
| 07/19/2007 | US20070167445 Androgen receptor modulator compounds and methods |
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof |
| 07/19/2007 | US20070167443 Substituted quinolones and methods of use |
| 07/19/2007 | US20070167442 Such as 1-(1-{3-[4-(ethylsulfonyl)piperazin-1-yl]-3-phenylpropyl}piperidin-4-yl)-5-(methylsulfonyl)-1H-benzimidazole; reductive amination |
| 07/19/2007 | US20070167441 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070167439 N4-(1-tert-Butoxycarbonylazetidin-3-yl)-5-fluoro-N2-(4-morpholinophenyl)-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE ("Fc epsilon RI") and IgG ("Fc gamma RI") antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 07/19/2007 | US20070167438 Treatment of substance abuse |
| 07/19/2007 | US20070167437 Antiproliferative agents; anticarcinogenic agents; cis-[4,5-Bis-(4-chloro-phenyl)-2-(4-ethoxy-2-trifluoromethyl-pyrimidin-5-yl)-4,5-dihydro-imidazol-1-yl]-[4-(2-methanesulfonyl-ethyl)-piperazin-1-yl]-methanone; inhibitors of the MDM2-p53 interaction |
| 07/19/2007 | US20070167436 Cyclohexyl piperazinyl methanone derivatives |
| 07/19/2007 | US20070167435 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders |
| 07/19/2007 | US20070167434 6,7,8,9-Substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents |
| 07/19/2007 | US20070167433 3,4,5-Substituted piperidines as therapeutic compounds |
| 07/19/2007 | US20070167432 Tricyclic triazolobenzapine derivative produced as novel crystalline substance |
| 07/19/2007 | US20070167431 Method for the treatment of cognitive dysfunction |
| 07/19/2007 | US20070167430 Compounds useful in therapy |
| 07/19/2007 | US20070167428 Thienopyrroles as antagonists of gnrh |
| 07/19/2007 | US20070167427 1,2,4-Triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
| 07/19/2007 | US20070167426 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 07/19/2007 | US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 07/19/2007 | US20070167424 Aztreonam L-lysine and methods for the preparation thereof |
| 07/19/2007 | US20070167423 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 07/19/2007 | US20070167422 Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin |
| 07/19/2007 | US20070167421 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 07/19/2007 | US20070167420 Process for preparing a crystalline form of halobetasol propionate |
| 07/19/2007 | US20070167419 Treatment for embolic stroke |
| 07/19/2007 | US20070167418 Progesterone/testosterone cream for erectile dysfunction |
| 07/19/2007 | US20070167417 Process for the production of a sterol-rich composition |
| 07/19/2007 | US20070167416 Administering 5-aminosalicylate (balsalazide) with food increases bioavailability; label on container recommends to take drug with food; inflammatory bowel disease, radiation enteritis, colon cancer; gastrointestinal disorders |
| 07/19/2007 | US20070167415 administering tetracycline derivatives such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline, thiatetracycline or 6-cyclopentylsulfanylmethyl doxycycline, to control parasitic infection and related disorders in a mammals |
| 07/19/2007 | US20070167414 Novel antibacterial agents |
| 07/19/2007 | US20070167413 Novel heterocycles |
| 07/19/2007 | US20070167412 Halocombstatins and methods of synthesis thereof |
| 07/19/2007 | US20070167411 Compositions for treating angina |
| 07/19/2007 | US20070167410 cyclic oximes useful in treatment or prevention of diseases mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction; 3-{[5-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-5,6,7,8-tetrahydro-naphthalen-2-ylmethyl]-amino}-propionic acid |
| 07/19/2007 | US20070167409 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 07/19/2007 | US20070167408 Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof |
| 07/19/2007 | US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 07/19/2007 | US20070167405 Galectins -1 and -4 in tumor development |
| 07/19/2007 | US20070167404 Surgical compositions for reducing the incidence of adhesions |
| 07/19/2007 | US20070167403 Remedy for spinal canal stenosis |
| 07/19/2007 | US20070167402 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| 07/19/2007 | US20070167401 novel cyclodextrin derivatives, polysubstituted but also monosubstituted, in primary alcohol position by reacting halogenated cyclodextrin with aminoalkanethiol or the salt of aminoalklanethio to form intermediate, then with an isothiocyanate containing biorecognition element such as amino acid, peptide |
| 07/19/2007 | US20070167400 Chitosan oligosaccharides and uses thereof |
| 07/19/2007 | US20070167399 Therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder |
| 07/19/2007 | US20070167398 Methods and compositions for reducing inflammation and preventing oxidative damage |
| 07/19/2007 | US20070167397 Methods and compositions for joint lubrication |
| 07/19/2007 | US20070167396 Methods and compositions for cholesterol reduction in mammals |
| 07/19/2007 | US20070167395 Compositions and methods for treating diabetes |
| 07/19/2007 | US20070167389 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070167383 Nucleoside compounds for treating viral infections |
| 07/19/2007 | US20070167382 Crystalline and amorphous forms of telithromycin |
| 07/19/2007 | US20070167381 Macrolides with antiinflammatory activity |
| 07/19/2007 | US20070167380 Taste masked compositions of erythromycin a and derivatives thereof |
| 07/19/2007 | US20070167379 Use of spinosyns for wound healing |
| 07/19/2007 | US20070167378 Iodinated diflunisal derivatives, e.g., 5-(2,4-difluorophenyl)-3-iodo-salicylic acid and N-[5-(2,4-difluorophenyl)-3-iodo-salicyloyl]glycine; treatment of neurodegenerative diseases and other conditions such as polyneuropathies and rheumatic diseases |
| 07/19/2007 | US20070167377 Inhibitors of glycinamide ribonucleotide transformylase |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167368 Dried blood factor composition comprising trehalose |
| 07/19/2007 | US20070167364 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/19/2007 | US20070167360 Methods for treating multiple sclerosis |
| 07/19/2007 | US20070167358 Prevention and treatment of ocular side effects with a cyclosporin |
| 07/19/2007 | US20070167355 Dietary and pharmaceutical compositions for management and treatment of oxidative stress |
| 07/19/2007 | US20070167353 Prodrug composition |
| 07/19/2007 | US20070167350 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166798 Isolating chondroitin sulfate |
| 07/19/2007 | US20070166797 Devices and solutions for prevention of sexually transmitted diseases |
| 07/19/2007 | US20070166780 Method for rapid detection and evaluation of cultured cell growth |
| 07/19/2007 | US20070166753 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 07/19/2007 | US20070166717 Methods and materials for assessing prostate cancer therapies |
| 07/19/2007 | US20070166710 Methods for inhibiting adipogenesis and for treating type 2 diabetes |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166418 Treatment modalities for autoimmune diseases |
| 07/19/2007 | US20070166417 Formulation and Methods for Use of Morinda Citrifolia Seed Oil |
| 07/19/2007 | US20070166416 Formulations and Methods for Preventing and Treating Substance Abuse and Addiction |
| 07/19/2007 | US20070166415 Safe medicine for treating and preventing cancer and method of use |
| 07/19/2007 | US20070166414 Method for enhancing tamoxifen efficacy as a cancer therapeutic |
| 07/19/2007 | US20070166413 Cholestrol-reducing agent containing an n-3 fatty acid |